France· FR:65212047
TAVLESSE 150 mg, comprimé pelliculé
A medicinal product containing fostamatinib disodique hexahydraté, registered in France by INSTITUTO GRIFOLS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FOSTAMATINIB DISODIQUE HEXAHYDRATÉ
- Manufacturer
- INSTITUTO GRIFOLS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302078191 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)EUR 1.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fostamatinib disodique hexahydraté in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTavlesse 150 mgInstituto Grifols
- CzechiaTAVLESSEInstituto Grifols, S.A., Barcelona
- SpainTAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAInstituto Grifols S.A.
- FinlandTavlesseInstituto Grifols S.A.
- IrelandTavlesse 150 mg film-coated tabletsInstituto Grifols S.A.
- IcelandTAVLESSEInstituto Grifols S.A.*
- NetherlandsTavlesse 150 mg filmomhulde tablettenInstituto Grifols S.A.
- NorwayTavlesseInstituto Grifols S.A
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tavlesse
- Liechtenstein · Tavlesse
- Norway · Tavlesse
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2574bd23-50be-49c1-80d0-d5cbb67698d2 GET /v1/drugs/2574bd23-50be-49c1-80d0-d5cbb67698d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65212047",
"date_amm": "2020-01-09",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1405",
"substance": "FOSTAMATINIB DISODIQUE HEXAHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about fostamatinib disodique hexahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.